DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Tex; Department of Vascular Surgery and Kidney Transplantation, University Hospital of Strasbourg, Strasbourg, France.
DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Tex.
J Vasc Surg Venous Lymphat Disord. 2017 Jan;5(1):60-69. doi: 10.1016/j.jvsv.2016.07.010. Epub 2016 Sep 28.
OBJECTIVE: Endovascular recanalization is considered first-line therapy for chronic central venous occlusion (CVO). Unlike arteries, in which landmarks such as wall calcifications provide indirect guidance for endovascular navigation, sclerotic veins without known vascular branching patterns impose significant challenges. Therefore, safe wire access through such chronic lesions mostly relies on intuition and experience. Studies have shown that magnetic resonance venography (MRV) can be performed safely in these patients, and the boundaries of occluded veins may be visualized on specific MRV sequences. Intraoperative image fusion techniques have become more common to guide complex arterial endovascular procedures. The aim of this study was to assess the feasibility and utility of MRV and intraoperative cone-beam computed tomography (CBCT) image fusion technique during endovascular CVO recanalization. METHODS: During the study period, patients with symptomatic CVO and failed standard endovascular recanalization underwent further recanalization attempts with use of intraoperative MRV image fusion guidance. After preoperative MRV and intraoperative CBCT image coregistration, a virtual centerline path of the occluded segment was electronically marked in MRV and overlaid on real-time two-dimensional fluoroscopy images. Technical success, fluoroscopy times, radiation doses, number of venograms before recanalization, and accuracy of the virtual centerline overlay were evaluated. RESULTS: Four patients underwent endovascular CVO recanalization with use of intraoperative MRV image fusion guidance. Mean (± standard deviation) time for image fusion was 6:36 ± 00:51 mm:ss. The lesion was successfully crossed in all patients without complications. Mean fluoroscopy time for lesion crossing was 12.5 ± 3.4 minutes. Mean total fluoroscopy time was 28.8 ± 6.5 minutes. Mean total radiation dose was 15,185 ± 7747 μGy/m, and mean radiation dose from CBCT acquisition was 2788 ± 458 μGy/m (18% of mean total radiation dose). Mean number of venograms before recanalization was 1.6 ± 0.9, whereas two lesions were crossed without any prior venography. On qualitative analysis, virtual centerlines from MRV were aligned with actual guidewire trajectory on fluoroscopy in all four cases. CONCLUSIONS: MRV image fusion is feasible and may improve success, safety, and the surgeon's confidence during CVO recanalization. Similar to arterial interventions, three-dimensional MRV imaging and image fusion techniques could foster innovative solutions for such complex venous interventions and have the potential to affect a great number of patients.
目的:血管内再通被认为是慢性中心静脉闭塞(CVO)的一线治疗方法。与动脉不同,动脉中的壁钙化等标志为血管内导航提供间接指导,而硬化静脉没有已知的血管分支模式,这带来了重大挑战。因此,安全地通过这些慢性病变的导丝主要依赖于直觉和经验。研究表明,这些患者可以安全地进行磁共振静脉造影(MRV),并且闭塞静脉的边界可以在特定的 MRV 序列上可视化。术中图像融合技术已越来越多地用于指导复杂的动脉血管内手术。本研究旨在评估 MRV 和术中锥形束 CT(CBCT)图像融合技术在血管内 CVO 再通中的可行性和实用性。
方法:在研究期间,因症状性 CVO 和标准血管内再通失败而接受进一步再通尝试的患者,采用术中 MRV 图像融合引导进行再通。在术前 MRV 和术中 CBCT 图像配准后,在 MRV 中电子标记闭塞段的虚拟中心线路径,并将其叠加到实时二维透视图像上。评估技术成功率、透视时间、辐射剂量、再通前静脉造影次数和虚拟中心线叠加的准确性。
结果:四名患者接受了术中 MRV 图像融合引导下的血管内 CVO 再通。图像融合的平均(±标准差)时间为 6:36±00:51mm:ss。所有患者均成功穿过病变,无并发症。病变穿越的平均透视时间为 12.5±3.4 分钟。总透视时间的平均为 28.8±6.5 分钟。总辐射剂量平均为 15185±7747μGy/m,CBCT 采集的辐射剂量平均为 2788±458μGy/m(总辐射剂量的 18%)。再通前静脉造影的平均次数为 1.6±0.9,而有两个病变在没有任何先前静脉造影的情况下被穿过。在定性分析中,在所有四个病例中,MRV 的虚拟中心线与透视时的实际导丝轨迹对齐。
结论:MRV 图像融合是可行的,可能会提高 CVO 再通的成功率、安全性和术者信心。与动脉介入类似,三维 MRV 成像和图像融合技术可为复杂静脉介入提供创新性解决方案,并有可能影响大量患者。
J Vasc Surg Venous Lymphat Disord. 2016-9-28
Methodist Debakey Cardiovasc J. 2018
Cardiovasc Intervent Radiol. 2015-4
Ann Vasc Surg. 2018-10
J Vasc Surg Venous Lymphat Disord. 2022-11
Cardiovasc Intervent Radiol. 2017-11
JMIR Serious Games. 2022-9-23
Methodist Debakey Cardiovasc J. 2018